These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31209620)

  • 1. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
    Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
    Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
    Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
    Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
    Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
    Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
    Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
    Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
    Chapiro J; Duran R; Lin M; Schernthaner R; Lesage D; Wang Z; Savic LJ; Geschwind JF
    Eur Radiol; 2015 Jul; 25(7):1993-2003. PubMed ID: 25636420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
    Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
    Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative volumetric functional MR imaging: an imaging biomarker of early treatment response in hypo-vascular liver metastasis patients after yttrium-90 transarterial radioembolization.
    Zhu X; Sobhani F; Xu C; Pan L; Ghasebeh MA; Kamel IR
    Abdom Radiol (NY); 2016 Aug; 41(8):1495-504. PubMed ID: 26960726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Luo Y; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Zarghampour M; Khoshpouri P; Ameli S; Li Z; Hu D; Kamel IR
    Eur Radiol; 2019 Oct; 29(10):5160-5171. PubMed ID: 30877462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
    Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.
    Labeur TA; Runge JH; Klompenhouwer EG; Klümpen HJ; Takkenberg RB; van Delden OM
    Abdom Radiol (NY); 2019 Aug; 44(8):2740-2750. PubMed ID: 31069479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
    Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
    Bonekamp S; Jolepalem P; Lazo M; Gulsun MA; Kiraly AP; Kamel IR
    Radiology; 2011 Sep; 260(3):752-61. PubMed ID: 21771960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.